4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-027441
Options or other derivatives
- Director acquired 13,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Karah Hila Director | 2022-09-30 | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 | D | ||
Loading xslF345X03/ownership.xml…